These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32336832)

  • 21. Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.
    Fierbinteanu-Braticevici C; Sinescu C; Moldoveanu A; Petrisor A; Diaconu S; Cretoiu D; Braticevici B
    Cell Biol Toxicol; 2017 Feb; 33(1):5-14. PubMed ID: 27680752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of bariatric surgery on nonalcoholic fatty liver disease.
    de Freitas AC; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):267-74. PubMed ID: 18403923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study.
    Jafarov F; Kaya E; Bakir A; Eren F; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2020 May; 32(5):642-649. PubMed ID: 31651653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease remission in men through regular exercise.
    Osaka T; Hashimoto Y; Hamaguchi M; Kojima T; Obora A; Fukui M
    J Clin Biochem Nutr; 2018 May; 62(3):242-246. PubMed ID: 29892163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK
    J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis.
    Vakhrushev YM; Lukashevich АР; Penkina IA; Suchkova EV
    Ter Arkh; 2019 Mar; 91(2):48-51. PubMed ID: 31094171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Esterson YB; Grimaldi GM
    Clin Liver Dis; 2018 Feb; 22(1):93-108. PubMed ID: 29128063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
    Yang S; Kwak S; Lee JH; Kang S; Lee SP
    PLoS One; 2019; 14(11):e0224626. PubMed ID: 31682638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease.
    Liu H; Zhang C; Xiong J
    Kidney Dis (Basel); 2022 Dec; 8(6):458-465. PubMed ID: 36590682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.
    Pirmoazen AM; Khurana A; El Kaffas A; Kamaya A
    Theranostics; 2020; 10(9):4277-4289. PubMed ID: 32226553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Sumida Y; Nakajima A; Itoh Y
    World J Gastroenterol; 2014 Jan; 20(2):475-85. PubMed ID: 24574716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    Lee YS; Lee JE; Yi HS; Jung YK; Jun DW; Kim JH; Seo YS; Yim HJ; Kim BH; Kim JW; Lee CH; Yeon JE; Lee J; Um SH; Byun KS
    Hepatol Int; 2022 Apr; 16(2):316-324. PubMed ID: 35254642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Meta-Analysis of Sleep Disorders and Nonalcoholic Fatty Liver Disease: Potential Causality and Symptom Management.
    Yu L; Lin C; Chen X; Teng Y; Zhou S; Liang Y
    Gastroenterol Nurs; 2022 Sep-Oct 01; 45(5):354-363. PubMed ID: 35913418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose.
    Jiang W; Jin Q; Li C; Xun Y
    Turk J Gastroenterol; 2023 Nov; ():. PubMed ID: 37966266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of sympathovagal balance by HRV analysis in alcoholic and nonalcoholic fatty liver disease patients.
    Uchil DN; Moosabba MS; Kalpana B; Grrishma B
    J Educ Health Promot; 2023; 12():400. PubMed ID: 38333143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease is associated with decreased lung function.
    Lee CH; Choi SH; Chung GE; Park B; Kwak MS
    Liver Int; 2018 Nov; 38(11):2091-2100. PubMed ID: 29660233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.